SEC Form 4 · accession 0001652917-15-000007
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Neil Stahl
Officer — EVP Research and Development
Period of report
Nov 5, 2015
Accepted (ET)
Nov 9, 2015 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 28, 2015 | G | 1,000 | $0.00 | D | 16,405 | D | |
| Common Stock | Nov 5, 2015 | M | 75,000 | $30.63 | A | 97,029 | D | |
| Common Stock | Nov 5, 2015 | F | 4,047 | $567.63 | D | 92,982 | D | |
| Common Stock | Nov 5, 2015 | F | 39,605 | $567.63 | D | 53,377 | D | |
| Common Stock | Nov 5, 2015 | M | 25,000 | $21.25 | A | 78,377 | D | |
| Common Stock | Nov 5, 2015 | F | 935 | $567.63 | D | 77,442 | D | |
| Common Stock | Nov 5, 2015 | F | 13,312 | $567.63 | D | 64,130 | D | |
| Common StockF1 | Nov 6, 2015 | S | 9,555 | $562.37 | D | 54,575 | D | |
| Common StockF2 | Nov 6, 2015 | S | 8,345 | $563.43 | D | 46,230 | D | |
| Common StockF3 | Nov 6, 2015 | S | 2,100 | $564.19 | D | 44,130 | D | |
| Common StockF4 | Nov 9, 2015 | S | 9,694 | $558.37 | D | 34,436 | D | |
| Common StockF5 | Nov 9, 2015 | S | 1,500 | $559.26 | D | 32,936 | D | |
| Common StockF6 | Nov 9, 2015 | S | 3,900 | $560.31 | D | 29,036 | D | |
| Common StockF7 | Nov 9, 2015 | S | 500 | $561.36 | D | 28,536 | D | |
| Common StockF8 | Nov 9, 2015 | S | 5,607 | $562.31 | D | 22,929 | D | |
| Common StockF9 | Nov 9, 2015 | S | 900 | $563.41 | D | 22,029 | D | |
| Common Stock | holding | — | — | — | 14,376 | I | by GRAT | |
| Common Stock | holding | — | — | — | 5,599 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 10,000 | I | by GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F10 | $21.25 | Nov 5, 2015 | M | 25,000 | D | — | Dec 18, 2019 | Common Stock | 25,000 | 20,295 | D |
| Non-Qualified Stock Option (right to buy)F11 | $30.63 | Nov 5, 2015 | M | 75,000 | D | — | Dec 14, 2020 | Common Stock | 75,000 | 46,736 | D |
Explanation of responses
- F1Represents volume-weighted average price of sales of 9,555 shares of Company stock on November 6, 2015 at prices ranging from $562.00 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
- F10The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F11The option became exercisable with respect to all shares underlying the option on December 31, 2013, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2013.
- F2Represents volume-weighted average price of sales of 8,345 shares of Company stock on November 6, 2015 at prices ranging from $563.00 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 2,100 shares of Company stock on November 6, 2015 at prices ranging from $564.00 to $564.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 6, 2015 at each separate price.
- F4Represents volume-weighted average price of sales of 9,694 shares of Company stock on November 9, 2015 at prices ranging from $558.00 to $558.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
- F5Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 9, 2015 at prices ranging from $559.00 to $559.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
- F6Represents volume-weighted average price of sales of 3,900 shares of Company stock on November 9, 2015 at prices ranging from $560.00 to $560.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
- F7Represents volume-weighted average price of sales of 500 shares of Company stock on November 9, 2015 at prices ranging from $561.07 to $561.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
- F8Represents volume-weighted average price of sales of 5,607 shares of Company stock on November 9, 2015 at prices ranging from $562.00 to $562.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.
- F9Represents volume-weighted average price of sales of 900 shares of Company stock on November 9, 2015 at prices ranging from $563.00 to $563.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 9, 2015 at each separate price.